Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oculopharyngeal muscular dystrophy.

B Brais1, G A Rouleau, J P Bouchard

  • 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Campus Nôtre-Dame, Quebec, Canada.

Seminars in Neurology
|March 11, 2000
PubMed
Summary

Oculopharyngeal muscular dystrophy (OPMD) is a genetic disorder causing progressive muscle weakness. It results from expansions in the PABP2 gene, leading to toxic protein aggregates in muscle cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term response to aminopyridines in a cohort of patients with ataxia associated with downbeat nystagmus due to the FGF14 GAA expansion.

Neurologia·2026
Same author

Loss of dcst2 expression in male zebrafish is not associated with muscle hypertrophy.

Molecular genetics and genomics : MGG·2025
Same author

Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia.

Revue neurologique·2024
Same author

Posttranslational modifications & lithium's therapeutic effect-Potential biomarkers for clinical responses in psychiatric & neurodegenerative disorders.

Neuroscience and biobehavioral reviews·2021
Same author

The Canadian Neuromuscular Disease Registry 2010-2019: A Decade of Facilitating Clinical Research Througha Nationwide, Pan-NeuromuscularDisease Registry.

Journal of neuromuscular diseases·2020
Same author

Stress in Parents of Children With Genetically Determined Leukoencephalopathies: A Pilot Study.

Journal of child neurology·2020

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) is a rare, adult-onset genetic disorder.
  • It is characterized by progressive dysphagia, eyelid ptosis, and proximal limb weakness.
  • The condition has a worldwide distribution and is a significant cause of morbidity.

Purpose of the Study:

  • To elucidate the genetic basis and molecular mechanisms underlying oculopharyngeal muscular dystrophy.
  • To identify the specific gene mutations responsible for both autosomal dominant and recessive forms of OPMD.
  • To understand the pathological consequences of these mutations at the cellular level.

Main Methods:

  • Genetic analysis to identify mutations in the polyadenylation binding protein 2 (PABP2) gene.

Related Experiment Videos

  • Analysis of skeletal muscle biopsies to identify intranuclear filament inclusions.
  • Molecular modeling to understand the impact of repeat expansions on protein structure and function.

    • Main Results:

    • Autosomal dominant OPMD is linked to (GCG)8-13 repeat expansions in the PABP2 gene.
    • Autosomal recessive OPMD is associated with a double dose of a (GCG)7 PABP2 allele.
    • These expansions lead to a lengthened polyalanine tract, forming nondegradable nuclear filaments.

    Conclusions:

    • Polyalanine tract expansions in the PABP2 gene are the causative agents of OPMD.
    • The accumulation of nuclear filaments suggests a mechanism of polyalanine-induced nuclear toxicity.
    • Further research into these molecular mechanisms may lead to novel therapeutic strategies.